Deal Monitor: status at the end of Q3 2019
It’s time to make a top view status of the deal activity for the 150+ European listed biotech companies in our universe. The data below include deals from all categories (R&D collaborations, Out-Licensing deals, Supply/Distribution deals, JV, IP licensing, Sales/Divestments), except the in-licensing deals. Please refer to our introductory report for more details and explanations.[…]